Category Archives: FDA

FDA official, William Maisel, pleads guilty to crime, keeps job

April 24, 2013 By Steven E. Greer, MD In July of 2012, the New York Times reported on an FDA scandal of the agency spying on internal

Posted in - Medical Devices, FDA | Leave a comment

Smartphone apps to be regulated and taxed as medical devices

March 26, 2013 Which smartphone apps will the FDA label as a medical device making them taxable tax under

Posted in - Medical Devices, Congress, FDA | Leave a comment

High fructose consumption and fatty liver disease

Manal F. Abdelmalek, MD, MPH, of the Duke Medical Center’s Division of Gastroenterology/Hepatology

Posted in Diabetes and endocrinology, Duke, FDA, Pediatrics | Leave a comment

Reasons to Abandon Low-Density Lipoprotein Cholesterol Targets

Interviewed by Steven Greer, MD Harlan Krumholz, MD, cardiologist from Yale, discusses his open letter in the journal Circulation

Posted in - Policy, Cardiology, CMS, FDA, NIH, Yale | Leave a comment

The inadequate FDA medical device safety surveillance system: a case study

January 25, 2012 By Steven Greer, MD I have worn contact lenses for more than twenty years without any problems. But recently,

Posted in - Medical Devices, - Opinion, Congress, FDA | Leave a comment

The only 5-minutes of the Edwards Sapien AdCom you need to watch

Update: June 11, 2012 The FDA briefing documents for the June 13 advisory committee to review the PARTNER-

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA | Leave a comment

The CardioMEMS’ heart failure pressure measurement system

By Steven Greer, MD The CardioMEMS’ heart failure pressure measurement system will be evaluated by an FDA

Posted in - Medical Devices, Cardiology, FDA, Ohio State | Leave a comment

Interview with The Commissioner of the FDA

February 16,  2011- by Steven Greer, MD In Part 1 of our interview with Margaret Hamburg, MD, The Commissioner of the FDA, she discusses

Posted in FDA | Leave a comment

Exclusive: Why did Dr. Nissen resort to secret tapes?

February 23, 2010– By Steven E. Greer, MD Many in the cardiology community are a bit confused as to why Dr. Steven Nissen resorted

Posted in - Opinion, - Policy, Cardiology, Cleveland Clinic, FDA | Leave a comment